Browsing: legal

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

Gilead Sciences agreed to pay $45 million to settle allegations of paying kickbacks that improperly influenced prescriptions paid for by the Texas Medicaid program, the latest pharmaceutical company to reach a deal with the state over marketing practices.

Just one week after being granted the authority to kick providers off of federal health care programs, U.S. health officials are using it on adult day care centers in New York City they say are committing fraud.

Massachusetts regulators on Oct. 13 moved to revoke all of the nursing home licenses held by RegalCare, a New Jersey-based company that went on a buying spree in the state after the pandemic, slashed costs, and gutted the quality of care at many of its 12 homes.

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

For five years, biologist David Sabatini has replayed his downfall from the Massachusetts Institute of Technology in the back of his mind, like a movie on repeat.

The Department of Justice has a warning for health care executives: Don’t be another Theranos. 

The FTC and seven states on Tuesday asked a federal court to hold Shkreli in contempt for “flagrantly and repeatedly” violating a court order banning him from working in the pharmaceutical industry. 

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.